The association of the lipid profile with knee and hand osteoarthritis severity: the IMI-APPROACH cohort.
Function
Lipids
Osteoarthritis
Pain
Radiography
Journal
Osteoarthritis and cartilage
ISSN: 1522-9653
Titre abrégé: Osteoarthritis Cartilage
Pays: England
ID NLM: 9305697
Informations de publication
Date de publication:
08 2022
08 2022
Historique:
received:
22
12
2021
revised:
16
05
2022
accepted:
18
05
2022
pubmed:
2
6
2022
medline:
20
7
2022
entrez:
1
6
2022
Statut:
ppublish
Résumé
To investigate the association of the lipidomic profile with osteoarthritis (OA) severity, considering the outcomes radiographic knee and hand OA, pain and function. We used baseline data from the Applied Public-Private Research enabling OsteoArthritis Clinical Headway (APPROACH) cohort, comprising persons with knee OA fulfilling the clinical American College of Rheumatology classification criteria. Radiographic knee and hand OA severity was quantified with Kellgren-Lawrence sum scores. Knee and hand pain and function were assessed with validated questionnaires. We quantified fasted plasma higher order lipids and oxylipins with liquid chromatography with tandem mass spectrometry (LC-MS/MS)-based platforms. Using penalised linear regression, we assessed the variance in OA severity explained by lipidomics, with adjustment for clinical covariates (age, sex, body mass index (BMI) and lipid lowering medication), measurement batch and clinical centre. In 216 participants (mean age 66 years, mean BMI 27.3 kg/m Within the APPROACH cohort lipidomics explained a minor portion of the variation in OA severity, which was most evident for the outcome hand pain. Our results suggest that eicosanoids may be involved in OA severity.
Identifiants
pubmed: 35644463
pii: S1063-4584(22)00749-X
doi: 10.1016/j.joca.2022.05.008
pii:
doi:
Substances chimiques
Oxylipins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1062-1069Informations de copyright
Copyright © 2022. Published by Elsevier Ltd.